Abiopharma

Clinical trial NCT04403022 updates: 1. allocation: NA → NON_RANDOMIZED 2. intervention model: SINGLE_GROUP → PARALLEL

Clinical trial NCT05184556: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT05333068 updates: 1. primary completion date: 2026-03-16 → 2026-09-16 2. enrollment: 1222 → 1223 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06672978: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07290257: enrollment: 100 → 230 participants.

Clinical trial NCT06862791 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-25 → 2026-05-11 3. primary completion date: 2026-05-25 → 2026-05-11

KBRA Assigns Rating to Blue Owl Technology Finance Corp.s $500 Million Senior Unsecured Notes due 2029

Clinical trial NCT06411249: allocation: NON_RANDOMIZED → NA.

Clinical trial NCT07214662 updates: 1. completion date: 2030-04-01 → 2030-06-01 2. primary completion date: 2030-04-01 → 2030-06-01

Clinical trial NCT07527832 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-27 3. primary completion date: 2026-05-31 → 2026-05-27 4. enrollment type: ESTIMATED → ACTUAL